Triple therapy with telaprevir/boceprevir+pegylated-interferon+ribavirin can achieve excellent antiviral efficacy, but it can be burdened with resistance development at failure.
Gasbarrini, A., Siciliano, M., Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome, <<DIGESTIVE AND LIVER DISEASE>>, 2014; (Dicembre): N/A-N/A. [doi:10.1016/j.dld.2014.11.010] [http://hdl.handle.net/10807/63621]
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome
Gasbarrini, Antonio;Siciliano, Massimo
2014
Abstract
Triple therapy with telaprevir/boceprevir+pegylated-interferon+ribavirin can achieve excellent antiviral efficacy, but it can be burdened with resistance development at failure.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
